Pathway Financial Advisers’s Amgen AMGN Stock Holding History

Pathway Financial Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.55M	Sell	9,809 -78	-0.8%	-$26.7K	0.89%	39
2026 Q1	$3.48M	Sell	9,887 -5,382	-35%	-$1.92M	0.98%	36
2025 Q4	$5M	Sell	15,269 -116	-0.8%	-$36.8K	1.45%	17
2025 Q3	$4.3M	Buy	15,385 +694	+5%	+$201K	1.26%	24
2025 Q2	$4.1M	Buy	14,691 +197	+1%	+$55.8K	1.33%	21
2025 Q1	$4.52M	Buy	14,494 +519	+4%	+$153K	1.55%	17
2024 Q4	$3.64M	Buy	13,975 +132	+1%	+$39.2K	1.22%	25
2024 Q3	$4.46M	Buy	13,843 +419	+3%	+$137K	2.02%	12
2024 Q2	$4.16M	Buy	13,424 +257	+2%	+$75.5K	1.49%	16
2024 Q1	$3.74M	Sell	13,167 -262	-2%	-$76.7K	1.35%	22
2023 Q4	$3.87M	Sell	13,429 -34	-0.3%	-$9.26K	1.47%	15
2023 Q3	$3.62M	Buy	+13,463	New	+$3.36M	1.49%	15
2023 Q1	$2.93M	Sell	12,140 -22	-0.2%	-$5.4K	1.18%	25
2022 Q4	$3.19M	Buy	+12,162	New	+$3.26M	1.29%	20

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Pathway Financial Advisers's AMGN Position: Q2 2026 in Review

Pathway Financial Advisers reduced its Amgen (AMGN) stake by 0.79% in Q2 2026, selling an estimated $26.7K and leaving 9,809 shares worth $3.55M. The position accounts for 0.89% of the portfolio, ranked #39.

Pathway Financial Advisers first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $5M in Q4 2025. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Pathway Financial Advisers held 9,809 shares of Amgen worth $3.55M as of Q2 2026.
Pathway Financial Advisers sold 78 Amgen shares in Q2 2026, an estimated $26.7K.
Amgen made up 0.89% of Pathway Financial Advisers's portfolio in Q2 2026, its #39 holding.
Pathway Financial Advisers first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
Pathway Financial Advisers's Amgen position peaked at $5M in Q4 2025.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pathway Financial Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.